| Autor: |
Briel, Matthias, Schwartz, Gregory G., Thompson, Peter L., de Lemos, James A., Blazing, Michael A., van Es, Gerrit-Anne, Kavikcioglu, Meral, Arntz, Hans-Richard, den Hartog, Frank R., Veeger, J. G. M., Colivicchi, Furio, Dupuis, Jocelyn, Okazaki, Shinya, Wright, Scott, Bucher, Heiner C., Nordmann, Alain J. |
| Předmět: |
|
| Zdroj: |
JAMA: Journal of the American Medical Association; 5/3/2006, Vol. 295 Issue 17, p2046-2056, 11p, 1 Diagram, 7 Charts, 4 Graphs |
| Abstrakt: |
This article attempts to evaluate relevant outcomes of patients from randomized controlled trials comparing early statin therapy with placebo or usual care at one and four months following acute coronary syndromes (ACS). The short-term impact of early treatment with statins in patients after the onset of ACS for the outcomes of death, myocardial infarction, and stroke is unknown. The authors concluded that, based on the available evidence, initiation of statin therapy within 14 days following onset of ACS does not reduce death, myocardial infarction, or stroke up to four months. |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
